Cargando…
Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus
BACKGROUND: Intravenous corticosteroid is the mainstay for managing acute severe ulcerative colitis, but one-third of patients do not respond to intravenous corticosteroid. Tacrolimus, a salvage therapy before colectomy, is usually orally administered, though its bioavailability is low compared intr...
Autores principales: | Shimizu, Hiromichi, Fujii, Toshimitsu, Kinoshita, Kenji, Kawamoto, Ami, Hibiya, Shuji, Takenaka, Kento, Saito, Eiko, Nagahori, Masakazu, Ohtsuka, Kazuo, Watanabe, Mamoru, Okamoto, Ryuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705155/ https://www.ncbi.nlm.nih.gov/pubmed/34949172 http://dx.doi.org/10.1186/s12876-021-02043-6 |
Ejemplares similares
-
Tacrolimus for the Treatment of Ulcerative Colitis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2015) -
Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
por: Shimizu, Hiromichi, et al.
Publicado: (2021) -
Mucosal healing of small intestinal stricture is associated with improved prognosis post-dilation in Crohn’s disease
por: Hibiya, Shuji, et al.
Publicado: (2022) -
Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab
por: Fujiwara, Shun, et al.
Publicado: (2022) -
Artificial intelligence for endoscopy in inflammatory bowel disease
por: Takenaka, Kento, et al.
Publicado: (2022)